As demonstrated in tables 1 and 2, ACSL4 mRNA is significantly overexpressed in TNBC and basal-like breast cancers, while ACSL3 mRNA expression predominates in RPBC and luminal and HER2-enriched subtypes. The gene discussed is ACSL3; the disease is breast cancer.